Intravenous Magnesium for Chronic Complex Regional Pain Syndrome Type 1 (CRPS-1)

被引:20
|
作者
Fischer, Sigrid G. L. [1 ,2 ,3 ]
Collins, Susan [1 ,2 ,3 ]
Boogaard, Sabine [1 ,2 ,3 ]
Loer, Stephan A. [1 ]
Zuurmond, Wouter W. A. [1 ,3 ]
Perez, Roberto S. G. M. [1 ,2 ,3 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, NL-1081 HV Amsterdam, Netherlands
[2] EMGO Inst Hlth & Care Res EMGO, Amsterdam, Netherlands
[3] Knowledge Consortium Trauma Related Neural Dysfun, Leiden, Netherlands
关键词
CRPS-1; NMDA Receptor; Magnesium; Central Sensitization; SYNDROME-TYPE-I; REFLEX SYMPATHETIC DYSTROPHY; IMPAIRMENT LEVEL SUMSCORE; ONE UPPER EXTREMITY; NEUROPATHIC PAIN; CENTRAL SENSITIZATION; SULFATE; QUESTIONNAIRE; SAFETY; RECOMMENDATIONS;
D O I
10.1111/pme.12211
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Abstract Objective To assess the effects of intravenous administration of magnesium on complex regional pain syndrome type 1 (CRPS-1), a randomized double-blind placebo-controlled trial was performed. Methods Fifty-six patients with CRPS-1 (International Association for the Study of Pain Orlando criteria) received MgSO4 70 mg/kg or placebo (NaCl 0.9%) in 4 hours over 5 consecutive days. Pain (BOX-11 and McGill), the level of impairment (Impairment level Sum Score [ISS]), functional limitations (Radboud Skills Questionnaire, Walking Skills Questionnaire/questionnaire rising and sitting down), participation (Impact on Participation and Autonomy [IPA]), and quality of life (Short Form-36, EuroQol, IPA) were evaluated at baseline and at 1, 3, 6, and 12 weeks. Results No significant differences were found between MgSO4 and placebo on the BOX-11 and ISS at different time points during the trial on intention-to-treat and per-protocol analysis. A significant improvement on the BOX-11 was found after the first week of the trial in both groups (mean 0.7; standard deviation 1.1). For the MgSO4 group, a clinically relevant and statistically significant improvement on the ISS at 1 week (median 5, interquartile range [IQR] -1 to 8) and a significant improvement on the McGill up to 6 weeks (median 2 words, IQR 0-4.5) were found compared with baseline, which were not found in the placebo group. Significant improvement in perceived job participation was found for the MgSO4 group at 12 weeks (median improvement 1.44-1.17; P = 0.01). ISS improved significantly more in patients with a low Hospital Anxiety and Depression Scale (HADS) score (<= 10) in the MgSO4 group (mean 4.4 vs mean -3.1; P = 0.02). Conclusion Administration of the physiological competitive N-methyl-D-aspartate receptor antagonist magnesium in chronic CRPS provides insufficient benefit over placebo. Future research should focus on patients with acute CRPS and early signs and symptoms of central sensitization.
引用
收藏
页码:1388 / 1399
页数:12
相关论文
共 50 条
  • [1] Intravenous Magnesium for Complex Regional Pain Syndrome Type 1 (CRPS 1) Patients: A Pilot Study
    Collins, Susan
    Zuurmond, Wouter W. A.
    de lange, Jaap J.
    van Hilten, Bob J.
    Perez, Roberto S. G. M.
    PAIN MEDICINE, 2009, 10 (05) : 930 - 940
  • [2] Chiropractic Care of a Patient With Complex Regional Pain Syndrome Type 1 (CRPS-1): A Case Report
    Szynkowicz, Peter
    Petrucci, Anthony
    JOURNAL OF CHIROPRACTIC MEDICINE, 2020, 19 (02) : 145 - 151
  • [3] Photoacoustic microscopy of complex regional pain syndrome type I (CRPS-1) after stellate ganglion blocks in vivo
    Zhou, Yong
    Yi, Xiaobin
    Xing, Wenxin
    Hu, Song
    Maslov, Konstantin I.
    Wang, Lihong V.
    PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2015, 2015, 9323
  • [4] Complex regional pain syndrome (CRPS 1)
    Meier, G
    AKTUELLE RHEUMATOLOGIE, 2004, 29 (03) : 155 - 157
  • [5] Referred sensations in patients with complex regional pain syndrome type 1 (CRPS).
    McCabe, CS
    Blake, DR
    Halligan, PW
    Haigh, RC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S410 - S410
  • [6] Complex regional pain syndrome type I (CRPS type 1/"RSD") - An overview
    Arkudas, A
    Kneser, U
    Horch, RE
    ZENTRALBLATT FUR CHIRURGIE, 2006, 131 (03): : W40 - W48
  • [7] CENTRAL SENSORY REORGANISATION IN COMPLEX REGIONAL PAIN SYNDROME TYPE 1 (CRPS)
    McCabe, C. S.
    Blake, D. R.
    Halligan, P. W.
    Haigh, R. C.
    RHEUMATOLOGY, 2002, 41 : 51 - 51
  • [8] Importance of early diagnosis of complex regional pain syndrome (CRPS-1 and C RPS-2): Delayed diagnosis of CRPS is a major problem
    Breivik, Harald
    Stubhaug, Audun
    SCANDINAVIAN JOURNAL OF PAIN, 2016, 11 : 49 - 51
  • [9] INTRAVENOUS BISPHOSPHONATE REDUCES RAPIDLY PAIN IN COMPLEX REGIONAL PAIN SYNDROME (CRPS)
    Bartoli, F.
    Fiori, G.
    Peruzzi, F.
    Guidi, G.
    Pfanner, S.
    Ceruso, M.
    Cerinic, M. Matucci
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 717 - 717
  • [10] Stroke Cured A Chronic Complex Regional Pain Syndrome (CRPS)
    Nasim, A.
    Pasco, K.
    Daniela, T.
    Blight, A.
    CEREBROVASCULAR DISEASES, 2013, 35 : 346 - 346